Ginkgo Bioworks Holdings, (id:9338 DNA)
7.18 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 9:25:16 PM)
Exchange closed, opens in 12 hours 4 minutes
8.13 USD (8.13%)
11.66 USD (11.66%)
-13.49 USD (-13.49%)
-73.37 USD (-73.37%)
-87.53 USD (-87.53%)
-98.39 USD (-98.39%)
About Ginkgo Bioworks Holdings,
Market Capitalization 486.84M
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| Headquarters (address) |
27 Drydock Avenue Boston 02210 MA United States |
| Phone | 877 422 5362 |
| Website | https://www.ginkgobioworks.com |
| Employees | 1,218 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | DNA |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 5.26 - 75.20 |
| Market Capitalization | 486.84M |
| P/E trailing | -0.390 |
| P/E forward | -1.05 |
| Price/Sale | 2.64 |
| Price/Book | 0.523 |
| Beta | 1.10 |
| EPS | -17.24 |
| EPS United States (ID:6, base:3402) | 24.23 |